Medical Aesthetic Filler are injected under the skin to restore lost volume, smooth and soften wrinkles or enhance facial contours. Injectable dermal fillers have developed rapidly and are getting closer and closer to "perfect" products: long-lasting but non-permanent, high tolerability, exquisite and natural cosmetic effects, and reversible in the event of adverse surgical outcomes.
Medical Aesthetic Dermal Filler Market contains market size and forecasts of Medical Aesthetic Dermal Filler in global, including the following market information:
- Global Medical Aesthetic Dermal Filler Market Revenue, 2018-2023, 2023-2030, ($ millions)
- Global Medical Aesthetic Dermal Filler Market Sales, 2018-2023, 2023-2030, (Units)
Global top five Medical Aesthetic Dermal Filler companies in 2022 (%)
The global Medical Aesthetic Dermal Filler market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Hyaluronic Acid Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Medical Aesthetic Dermal Filler include AbbVie, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma, Beijing IMEIK and Bloomage Bio, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Medical Aesthetic Dermal Filler manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Aesthetic Dermal Filler Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Medical Aesthetic Dermal Filler Market Segment Percentages, by Type, 2022 (%)
- Hyaluronic Acid
- Collagen
- CaHA
- Others
Global Medical Aesthetic Dermal Filler Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Medical Aesthetic Dermal Filler Market Segment Percentages, by Application, 2022 (%)
Global Medical Aesthetic Dermal Filler Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Medical Aesthetic Dermal Filler Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Medical Aesthetic Dermal Filler revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Medical Aesthetic Dermal Filler revenues share in global market, 2022 (%)
- Key companies Medical Aesthetic Dermal Filler sales in global market, 2018-2023 (Estimated), (Units)
- Key companies Medical Aesthetic Dermal Filler sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie
- Galderma
- LG Life Sciences
- Merz
- Medytox
- HUGEL
- Croma-Pharma
- Beijing IMEIK
- Bloomage Bio
- Elravie (Humedix)
- Cleviel (Pharma Research Products)
- Haohai Biological
- Q.O.Fill (JW Pharmaceutical)
- Teoxane
- Sinclair
- Suneva Medical
- CG Bio
- SciVision Biotech
- Prollenium
- Matex-Lab
- Jingjia Medical
- Genoss
- Bohus BioTech
- Caregen
Industry Market Size
